-$2.5M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Tanimoto SarinaOct 8, 2024Sell50,000$13.8278$690,000
Lowenthal Richard EOct 8, 2024Sell50,000$13.8278$690,000
Karas EricSep 18, 2024Sell10,000$14$140,000
Tanimoto SarinaSep 17, 2024Sell50,000$12.9336$650,000
Lowenthal Richard ESep 17, 2024Sell50,000$12.9336$650,000
Tanimoto SarinaSep 10, 2024Sell50,000$11.4982$570,000
Lowenthal Richard ESep 10, 2024Sell50,000$11.4982$570,000
Thompson Peter A.Aug 26, 2024Sell83,695$13$1.1M
ORBIMED ADVISORS LLCAug 26, 2024Sell83,695$13$1.1M
Thompson Peter A.Aug 23, 2024Sell69,500$13.03$910,000
ORBIMED ADVISORS LLCAug 23, 2024Sell69,500$13.03$910,000
Thompson Peter A.Aug 22, 2024Sell391,482$12.94$5.1M
ORBIMED ADVISORS LLCAug 22, 2024Sell391,482$12.94$5.1M
Thompson Peter A.Aug 21, 2024Sell394,400$13.52$5.3M
ORBIMED ADVISORS LLCAug 21, 2024Sell394,400$13.52$5.3M
Thompson Peter A.Aug 21, 2024Sell13,300$14.61$190,000
ORBIMED ADVISORS LLCAug 21, 2024Sell13,300$14.61$190,000
Dorsey BrianAug 20, 2024Sell50,000$15$750,000
Scott Kathleen D.Aug 20, 2024Sell12,500$16$200,000
Tanimoto SarinaAug 20, 2024Sell36,216$14.7576$530,000
Tanimoto SarinaAug 20, 2024Sell35,944$14.7565$530,000
Tanimoto SarinaAug 20, 2024Sell11,756$15.6129$180,000
Tanimoto SarinaAug 20, 2024Sell11,523$15.6234$180,000
Lowenthal Richard EAug 20, 2024Sell36,216$14.7576$530,000
Lowenthal Richard EAug 20, 2024Sell35,944$14.7565$530,000
Lowenthal Richard EAug 20, 2024Sell11,756$15.6129$180,000
Lowenthal Richard EAug 20, 2024Sell11,523$15.6234$180,000
Tanimoto SarinaAug 20, 2024Sell2,300$16.2589$37,000
Tanimoto SarinaAug 20, 2024Sell2,261$16.2532$37,000
Lowenthal Richard EAug 20, 2024Sell2,300$16.2589$37,000
Lowenthal Richard EAug 20, 2024Sell2,261$16.2532$37,000
Karas EricAug 19, 2024Sell10,000$14$140,000
Dorsey BrianAug 13, 2024Sell30,000$13$390,000
Tanimoto SarinaAug 13, 2024Sell35,401$12.7646$450,000
Tanimoto SarinaAug 13, 2024Sell35,363$12.7659$450,000
Tanimoto SarinaAug 13, 2024Sell14,637$11.7734$170,000
Tanimoto SarinaAug 13, 2024Sell14,599$11.7753$170,000
Lowenthal Richard EAug 13, 2024Sell35,401$12.7646$450,000
Lowenthal Richard EAug 13, 2024Sell35,363$12.7659$450,000
Lowenthal Richard EAug 13, 2024Sell14,637$11.7734$170,000
Lowenthal Richard EAug 13, 2024Sell14,599$11.7753$170,000
Lowenthal Richard EJul 16, 2024Sell50,000$11.4031$570,000
Tanimoto SarinaJul 16, 2024Sell50,000$11.4031$570,000
Tanimoto SarinaJul 9, 2024Sell50,000$9.6168$480,000
Lowenthal Richard EJul 9, 2024Sell50,000$9.6168$480,000
Tanimoto SarinaJun 12, 2024Sell48,028$9.1447$440,000
Tanimoto SarinaJun 12, 2024Sell47,834$9.1454$440,000
Lowenthal Richard EJun 12, 2024Sell48,028$9.1447$440,000
Lowenthal Richard EJun 12, 2024Sell47,834$9.1454$440,000
Tanimoto SarinaJun 11, 2024Sell2,166$9.002$19,000
Tanimoto SarinaJun 11, 2024Sell1,972$9.0039$18,000
Lowenthal Richard EJun 11, 2024Sell2,166$9.002$19,000
Lowenthal Richard EJun 11, 2024Sell1,972$9.0039$18,000
Tanimoto SarinaMay 16, 2024Sell44,746$9.0581$410,000
Tanimoto SarinaMay 16, 2024Sell44,350$9.0577$400,000
Lowenthal Richard EMay 16, 2024Sell44,746$9.0581$410,000
Lowenthal Richard EMay 16, 2024Sell44,350$9.0577$400,000
Tanimoto SarinaMay 15, 2024Sell2,766$9.0403$25,000
Tanimoto SarinaMay 15, 2024Sell2,381$9.0547$22,000
Lowenthal Richard EMay 15, 2024Sell2,766$9.0403$25,000
Lowenthal Richard EMay 15, 2024Sell2,381$9.0547$22,000
Tanimoto SarinaMay 14, 2024Sell2,884$9.0058$26,000
Tanimoto SarinaMay 14, 2024Sell2,873$9.0084$26,000
Lowenthal Richard EMay 14, 2024Sell2,884$9.0058$26,000
Lowenthal Richard EMay 14, 2024Sell2,873$9.0084$26,000
Tanimoto SarinaMay 7, 2024Sell50,000$9.3446$470,000
Lowenthal Richard EMay 7, 2024Sell50,000$9.3446$470,000
Tanimoto SarinaApr 16, 2024Sell50,000$9.2797$460,000
Lowenthal Richard EApr 16, 2024Sell50,000$9.2797$460,000
Tanimoto SarinaApr 9, 2024Sell50,000$9.277$460,000
Lowenthal Richard EApr 9, 2024Sell50,000$9.277$460,000
RA Capital Healthcare Fund LPMar 27, 2024Buy505,954$9.79$5M
RA Capital Healthcare Fund LPMar 26, 2024Buy457,745$9.55$4.4M
RA Capital Healthcare Fund LPMar 25, 2024Buy437,600$9.06$4M
Lowenthal Richard EMar 25, 2024Sell47,635$9.1238$430,000
Lowenthal Richard EMar 25, 2024Sell47,632$9.1236$430,000
Tanimoto SarinaMar 25, 2024Sell47,635$9.1238$430,000
Tanimoto SarinaMar 25, 2024Sell47,632$9.1236$430,000
Lowenthal Richard EMar 22, 2024Sell1,326$9.0132$12,000
Lowenthal Richard EMar 22, 2024Sell1,017$9.0298$9,200
Tanimoto SarinaMar 22, 2024Sell1,326$9.0132$12,000
Tanimoto SarinaMar 22, 2024Sell1,017$9.0298$9,200
Lowenthal Richard EMar 21, 2024Sell372$9$3,300
Lowenthal Richard EMar 21, 2024Sell100$9$900
Tanimoto SarinaMar 21, 2024Sell372$9$3,300
Tanimoto SarinaMar 21, 2024Sell100$9$900
Lowenthal Richard EMar 19, 2024Sell976$9.0273$8,800
Lowenthal Richard EMar 19, 2024Sell942$9.0376$8,500
Tanimoto SarinaMar 19, 2024Sell976$9.0273$8,800
Tanimoto SarinaMar 19, 2024Sell942$9.0376$8,500
Lowenthal Richard EMar 15, 2024Sell48,461$9.1413$440,000
Lowenthal Richard EMar 15, 2024Sell48,295$9.1415$440,000
Tanimoto SarinaMar 15, 2024Sell48,461$9.1413$440,000
Tanimoto SarinaMar 15, 2024Sell48,295$9.1415$440,000
Lowenthal Richard EMar 14, 2024Sell239$9$2,200
Lowenthal Richard EMar 14, 2024Sell205$9$1,800
Tanimoto SarinaMar 14, 2024Sell239$9$2,200
Tanimoto SarinaMar 14, 2024Sell205$9$1,800
Lowenthal Richard EMar 13, 2024Sell1,500$9$14,000
Lowenthal Richard EMar 13, 2024Sell1,300$9$12,000
Tanimoto SarinaMar 13, 2024Sell1,500$9$14,000
Tanimoto SarinaMar 13, 2024Sell1,300$9$12,000
Tanimoto SarinaFeb 29, 2024Sell1,982$9.0144$18,000
Tanimoto SarinaFeb 29, 2024Sell1,000$9.019$9,000
Lowenthal Richard EFeb 29, 2024Sell1,982$9.0144$18,000
Lowenthal Richard EFeb 29, 2024Sell1,000$9.019$9,000
Tanimoto SarinaFeb 29, 2024Sell800$9.0188$7,200
Lowenthal Richard EFeb 29, 2024Sell800$9.0188$7,200
Tanimoto SarinaFeb 28, 2024Sell49,019$9.0212$440,000
Tanimoto SarinaFeb 28, 2024Sell25,456$9.0205$230,000
Tanimoto SarinaFeb 28, 2024Sell24,303$9.0205$220,000
Lowenthal Richard EFeb 28, 2024Sell49,019$9.0212$440,000
Lowenthal Richard EFeb 28, 2024Sell25,456$9.0205$230,000
Lowenthal Richard EFeb 28, 2024Sell24,303$9.0205$220,000
Tanimoto SarinaFeb 26, 2024Sell500$9.01$4,500
Tanimoto SarinaFeb 26, 2024Sell100$9.01$900
Lowenthal Richard EFeb 26, 2024Sell500$9.01$4,500
Lowenthal Richard EFeb 26, 2024Sell100$9.01$900
Fitzpatrick Alexander ASep 29, 2023Buy46,258$3.783$170,000
Fitzpatrick Alexander ASep 28, 2023Buy40,000$3.624$140,000
RA Capital Healthcare Fund LPSep 21, 2023Buy2,508,691$2.97$7.5M
RA Capital Healthcare Fund LPSep 21, 2023Buy191,309$3.83$730,000
Shawver LauraSep 1, 2023Sell100,000$7.7052$770,000
RA Capital Healthcare Fund LPAug 29, 2023Buy3,750,000$6.2$23M
ORBIMED ADVISORS LLCAug 29, 2023Buy500,000$6.2$3.1M
Thompson Peter A.Aug 29, 2023Buy500,000$6.2$3.1M
Shawver LauraAug 4, 2023Sell18,897$7.0631$130,000
Shawver LauraAug 3, 2023Sell26,107$7.0103$180,000
Shawver LauraAug 2, 2023Sell36,281$7.0909$260,000
Shawver LauraAug 1, 2023Sell18,715$7.1908$130,000
Shawver LauraJul 7, 2023Sell8,858$6.364$56,000
Shawver LauraJul 6, 2023Sell33,510$6.343$210,000
Shawver LauraJul 5, 2023Sell31,112$6.414$200,000
Shawver LauraJul 3, 2023Sell26,520$6.725$180,000
Shawver LauraJun 2, 2023Sell26,941$6.95$190,000
Shawver LauraJun 1, 2023Sell73,059$6.8$500,000
Shawver LauraMay 9, 2023Sell42,900$5.31$230,000
Shawver LauraMay 8, 2023Sell57,100$6.16$350,000
Scott Kathleen D.Nov 29, 2022Buy8,250$6.2432$52,000
Shawver LauraNov 9, 2022Sell43,896$4.58$200,000

What's the latest insider transaction for ARS Pharmaceuticals?

The most recent insider transaction for ARS Pharmaceuticals was conducted by Tanimoto Sarina, who sold 50,000 shares on October 8, 2024 at a price of $13.83 per share.

Which insider bought the most SPRY stock over the last two years?

RA Capital Healthcare Fund LP has bought the most SPRY stock in the last 2 years, with a total value of $45M.

Which insider has sold the most SPRY stock over the last two years?

ORBIMED ADVISORS LLC has sold the most SPRY stock in the last 2 years, with a total value of $13M.

What is the total value of insider transactions for ARS Pharmaceuticals (SPRY) in the last 2 years?

The total value of insider transactions for ARS Pharmaceuticals in the last 2 years is negative, amounting to -$2.5M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on ARS Pharmaceuticals' market confidence?

Over the last 2 years, insider transactions for ARS Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.